Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Largest Percentage growth candidate is DRAX -- Ignore unavailable to you. Want to Upgrade?

To: Cheryl Galt who wrote (4)	7/13/2001 8:12:21 PM
From: FML	Read Replies (1) \| Respond to of 13

Cheryl, I just looked at the older site on Draxis and if I am reading it right there haven't been any posts since last October. Am I reading it correctly ? Sorry that I started the new thread. Your message said you liked the connection Draxis has with Elan. ( Elan owns about 8% of Draxis ). Do you know whether Teva Phamaceutical ( Isreal ) ended up with the Draxis 2.3 million shares of Draxis that Novopharm and its CEO Leslie Dan owned, when Teva bought Novopharm last year, since I don't see the shares listed after Lelie Dan's name in this year report to shareholders ? Also April 30, 2001 Draxis Shareholder report shows that VanBerkhom and Assoicates of Montreal now owns a tad over 5 milliion shares (13.9%) of Draxis. And Samnuel Sarice Limited of Toronto had a tad over 1 million shares of Draxis. I am very impressed with Draxis future and have been a steady buyer of Draxis since the Autumn of 1999. My wife and were interested in Draxis before we went to the June annual meeting but we were even more enthusiastic after we returned from the meeting which was held at their new research laboratories and manufacturing facilities and after we heard the presentations of Dr Barkin the Draxis CEO and the head Dr. Flannagan the new president of Draximage division of Draxis. Dr. Flannagan spok on the current and developing Radiopharmacological product line. It looks as though all three divisions of Draxis are moving forward rather nicely. The next give news I'm waiting for is the FDA approval which gives Draximage the Green light to ship from its own manfucturing facilities ( instead of outside facilities ) into the U.S. market. The outside contract manufacturer they said is unable to meet the demand and Draxis newly enlarged facilities are ready to go once they get FDA approval to ship teh radiophama products out of the expanded facility. I know it's dangerous to get too enthusiastic with any stock and I keep re checking everything I can find on Draxis to look for a red flag. The bashers are thick and heavy at the Yahoo Draxis board and according to the recent Silicon Valley article on Bashers that is a good sign since they can only make money on a stock that will bounce back each time they can drive it down. Right now they are working the boards like mad to bash the stock down and any news that is positive is met with heavy bashing. If they get it back under $2.00 then I'll buy more, but one of these times they aren't going to be successful and I wont be able to buy additional shares under $2.00. Is this the time that they fail in beating it down ? Maybe..